Skip to main content
SpringerLink
Log in

Thrombotic and Hemostatic Aspects of Assisted Conception

  • Chapter
  • First Online:
Disorders of Thrombosis and Hemostasis in Pregnancy

  • 996 Accesses

Abstract

Assisted conception is a women’s health issue of growing importance, with the number of women undergoing in vitro fertilization (IVF) increasing world-wide. IVF treatment involves ovarian stimulation. This can result in a hyper-estrogenic state, which in turn can lead to ovarian hyperstimulation syndrome (OHSS) associated with both venous and arterial thromboembolism. This chapter addresses clinically relevant thrombotic and haemostatic aspects of assisted conception, including the diagnosis, treatment and prevention of OHSS-related thromboembolism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update. 2008;14(6):623–45.

    PubMed  CAS  Google Scholar 

  2. Mara M, Koryntova D, Rezabek K, et al. Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study. Ceska Gynekol. 2004;69:312–6 [Czech].

    PubMed  CAS  Google Scholar 

  3. Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21:207–18.

    Article  PubMed  Google Scholar 

  4. Aboulghar MA, Mansour RT, Serour GI, et al. Moderate Ovarian Hyperstimulation Syndrome complicated by deep cerebrovascular thrombosis. Hum Reprod. 1998;13:2088.

    Article  PubMed  CAS  Google Scholar 

  5. Hansen AT, Kesmodel US, Juul S, Hyas AM. No evidence that assisted reproduction increases the risk of thrombosis: a Danish National cohort study. Human Reproduction. 2012;27:1499–1503

    Article  PubMed  CAS  Google Scholar 

  6. Whelan JG, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:83–896.

    Article  Google Scholar 

  7. Douketis JD, Ginsberg JS, Holbrook A, et al. A reevaluation of the risk for Venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med. 1997;157:1522–30.

    Article  PubMed  CAS  Google Scholar 

  8. Rossouw JE, Anderson GL, Prentice RL, Writing Group for the Women’s Health Initiative Investigators, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321–33.

    Article  PubMed  CAS  Google Scholar 

  9. Biron C, Galtier-Dereure F, Rabesandratana H, et al. Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study. Fertil Steril. 1997;67:104–9.

    Article  PubMed  CAS  Google Scholar 

  10. Kim HC, Kemmann E, Shelden RM, Saidi P. Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins. Am J Obstet Gynecol. 1981;140:807–10.

    PubMed  CAS  Google Scholar 

  11. Aune B, Hoie KE, Oian P, et al. Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state? Hum Reprod. 1991;6:925–7.

    PubMed  CAS  Google Scholar 

  12. Rice VC, Richard-Davis G, Saleh AA, et al. Fibrinolytic parameters in women undergoing ovulation induction. Am J Obstet Gynecol. 1993;169:1549–53.

    PubMed  CAS  Google Scholar 

  13. Aune B, Oian P, Osterud B. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization. Hum Reprod. 1993;8:1349–52.

    PubMed  CAS  Google Scholar 

  14. Bremme K, Wramsby H, Andersson O, et al. Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis. 1994;5:205–10.

    Article  PubMed  CAS  Google Scholar 

  15. Andersson O, Blomback M, Bremme K, Wramsby H. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation. Thromb Haemost. 1997;77:901–4.

    PubMed  CAS  Google Scholar 

  16. Richard-Davis G, Montgomery-Rice V, Mammen EF, et al. In vitro platelet function in controlled ovarian hyperstimulation cycles. Fertil Steril. 1997;67:923–7.

    Article  PubMed  CAS  Google Scholar 

  17. Lox C, Canez M, Prien S. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism. Int J Fertil Womens Med. 1998;43:34–9.

    PubMed  CAS  Google Scholar 

  18. Magnani B, Tsen L, Datta S, Bader A. In vitro fertilization. Do short-term changes in estrogen levels produce increased fibrinolysis? Am J Clin Pathol. 1999;112:485–91.

    PubMed  CAS  Google Scholar 

  19. Curvers J, Nap AW, Thomassen MC, Nienhuis SJ, Hamulyak K, Evers JL, Tans G, Rosing J. Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway. Br J Haematol. 2001;115:400–7.

    Article  PubMed  CAS  Google Scholar 

  20. Harnett MJ, Bhavani-Shankar K, Datta S, Tsen LC. In vitro fertilization-induced alterations in coagulation and fibrinolysis as measured by thromboelastography. Anesth Analg. 2002;95:1063–6.

    PubMed  CAS  Google Scholar 

  21. Westerlund E, Henriksson P, Wallén H, Hovatta O, Wallberg KR, Antovic A.Thromb Res. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. 2012;130(4):649–53.

    Article  PubMed  CAS  Google Scholar 

  22. Bar J, Orvieto R, Lahav J, et al. Effect of urinary versus recombinant follicle stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation. Fertil Steril. 2004;82:1564–9.

    Article  PubMed  CAS  Google Scholar 

  23. Phillips LL, Gladstone W, Vande Wiele R, et al. Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J Reprod Med. 1975;14:138–43.

    PubMed  CAS  Google Scholar 

  24. Kodama H, Fukuda J, Karube H, et al. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril. 1996;66:417–24.

    PubMed  CAS  Google Scholar 

  25. Rogolino A, Coccia ME, Fedi S, et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis. 2002;14:27–282.

    Google Scholar 

  26. Bergh PA, Navot D. Ovarian hyperstimulation syndrome: a review of pathophysiology. J Assist Reprod Genet. 1992;9:429–38.

    Article  PubMed  CAS  Google Scholar 

  27. Koninckx PR, Heyns W, Verhoeven G, Van Baelen H, Lissens WD, et al. Biochemical characterization of peritoneal fluid in women during the menstrual cycle. J Clin Endocrinol Metab. 1980;51:1239–44.

    Article  PubMed  CAS  Google Scholar 

  28. Koninckx PR, Renaer M, Brosens IA. Origin of peritoneal fluid in women: an ovarian exudation product. Br J Obstet Gynaecol. 1980;87:177–83.

    Article  PubMed  CAS  Google Scholar 

  29. Donnez J, Langerock S, Thomas K. Peritoneal fluid volume and 17 bestradiol and progesterone concentrations in ovulatory, anovulatory and postmenopausal women. Obstet Gynecol. 1982;59:687–92.

    PubMed  CAS  Google Scholar 

  30. Sealey JE, Atlas SA, Glorioso N, Manapat H, Laragh JH. Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. Proc Natl Acad Sci U S A. 1985;82:8705–9.

    Article  PubMed  CAS  Google Scholar 

  31. Derkx FH, Alberda AT, Zeilmaker GH, Schalekamp MA. High concentrations of immunoreactive renin, prorenin and enzymatically-active renin in human ovarian follicular fluid. Br J Obstet Gynaecol. 1987;94:4–9.

    Article  PubMed  CAS  Google Scholar 

  32. Lightman A, Tarlatzis BC, Rzasa PJ, Culler MD, Caride VJ, NegroVilar AF, et al. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol. 1987;156:808–16.

    PubMed  CAS  Google Scholar 

  33. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril. 2000;74:429–38.

    Article  PubMed  CAS  Google Scholar 

  34. Cluroe AD, Synek BJ. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995;27:344–6.

    Article  PubMed  CAS  Google Scholar 

  35. Togay-Isikay C, Celik T, Ustuner I, Yigit A. Ischaemic stroke associated with ovarian hyperstimulation syndrome and factor V Leiden mutation. Aust N Z J Obstet Gynaecol. 2004;44:264–6.

    Article  PubMed  Google Scholar 

  36. Demirol A, Guven S, Gurgan T. Aphasia: an early uncommon complication of ovarian stimulation without ovarian hyperstimulation syndrome. Reprod Biomed Online. 2007;14:29–31.

    Article  PubMed  Google Scholar 

  37. Song TJ, Lee SY, Oh SH, Lee KY. Multiple cerebral infarctions associated with polycystic ovaries and ovarian hyperstimulation syndrome [letter]. Eur Neurol. 2008;59:76–8.

    Article  PubMed  Google Scholar 

  38. Bartkova A, Sanak D, Dostal J, et al. Acute ischaemic stroke in pregnancy: a severe complication of ovarian hyperstimulation syndrome. Neurol Sci. 2008;29:463–6.

    Article  PubMed  Google Scholar 

  39. Bauersachs RM, Manolopoulos K, Hoppe I, et al. More on: the ‘ART’ behind the clot – solving the mystery. J Thromb Haemost. 2007;5:438–9.

    Article  PubMed  CAS  Google Scholar 

  40. Salomon O, Schiby G, Heiman Z, et al. Combined jugular and subclavian vein thrombosis following assisted reproductive technology: new observation. Fertil Steril. 2009;92(2):620–5.

    Article  PubMed  Google Scholar 

  41. American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90:S188–93.

    Google Scholar 

  42. Royal College of Obstetricians and Gynaecologists. The management of ovarian hyperstimulation syndrome, green-TOP guideline no 5. London: RCOG Press; 2006.

    Google Scholar 

  43. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, and Kahn SR. Antithrombotic therapy for VTE Disease. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2)(Suppl):e419S–e494S.

    Google Scholar 

  44. Arya R, Shehata HA, Patel RK, Sahu S, Rajasingam D, Harrington KF, Nelson-Piercy C, Parsons JH. Internal jugular vein thrombosis after assisted conception therapy. Br J Haematol. 2001;115:153–5.

    Article  PubMed  CAS  Google Scholar 

  45. Hignett M, Spence JE, Claman P. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum Reprod. 1995;10:3121–3.

    PubMed  CAS  Google Scholar 

  46. McGowan BM, Kay LA, Perry DJ. Deep vein thrombosis followed by internal jugular vein thrombosis as a complication of in vitro fertilization in a woman heterozygous for the prothrombin 30 UTR and factor V Leiden mutations. Am J Hematol. 2003;73:276–8.

    Article  PubMed  CAS  Google Scholar 

  47. Mathur R, Evbuomwan I, Jenkins J. Prevention and management of ovarian hyperstimulation syndrome. Curr Obstet Gynaecol. 2005;15:132–8.

    Article  Google Scholar 

  48. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H. Clinical guidelines for testing for heritable thrombophilia. British Journal of Haematology. 2010;149:209–20.

    Article  PubMed  CAS  Google Scholar 

  49. Grandone E, Colaizzo D, Lo Bue A, Checola MG, Cittadini E, Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril. 2001;76:201–2.

    Article  PubMed  CAS  Google Scholar 

  50. Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, Khader YS. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006;21:2694–8.

    Article  PubMed  CAS  Google Scholar 

  51. Azem F, Many A, Yovel I, Amit A, Lessing JB, Kupferminc MJ. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368–70.

    Article  PubMed  Google Scholar 

  52. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online. 2006;12:322–7.

    Article  PubMed  Google Scholar 

  53. Balasch J, Fabregues F, Creus M, Reverter JC, Carmona F, Tassies D, Font J, Vanrell JA. Pregnancy: antiphospholipid antibodies and human reproductive failure. Hum Reprod. 1996;11:2310–5.

    Article  PubMed  CAS  Google Scholar 

  54. Vaquero E, Lazzarin N, Caserta D, Valensise H, Baldi M, Moscarini M, Arduini D. Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. Eur J Obstet Gynecol Reprod Biol. 2006;125:79–84.

    Article  PubMed  Google Scholar 

  55. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, De Groot PG, Koike T, Meroni PL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

    Article  PubMed  CAS  Google Scholar 

  56. Buckingham KL and Chamley LW. A critical assessment of the role of antiphospholipid antibodies in infertility. J Reprod Immunol 2009;80:132–45

    Article  PubMed  CAS  Google Scholar 

  57. Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akash H, Bdoor AN, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, ­Abu-Salim A. Low-molecular weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomised placebo-controlled trial. Hum Fertil (Camb). 2008;11(4):246–53.

    Article  PubMed  CAS  Google Scholar 

  58. Mancini A, Milardi D, Di Pietro ML, Giacchi E, Spagnolo AG, Di Donna V, De Marinis L, Jensen L. A case of forearm amputation after ovarian stimulation for IVF-ET. Fertil Steril. 2001;76(1):198–200.

    Article  PubMed  CAS  Google Scholar 

  59. McGovan B, Kay L, Perry D. DVT followed by internal jugular vein thrombosis as a complication of IVF in a woman heterozygous for the prothrombin 3’UTR and factor V Leiden mutations. Am J Hematol. 2003;73:276–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Reproductive and Genetic Health (CRGH), Eastman Dental Hospital, 256 Gray’s Inn Road, London, WC1X 8LD, UK

    Irfana Koita-Kazi MRCOG & Paul Serhal MRCOG

Authors
  1. Irfana Koita-Kazi MRCOG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Serhal MRCOG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irfana Koita-Kazi MRCOG .

Editor information

Editors and Affiliations

  1. Aberdare Gardens 36, London, NW6 3QA, United Kingdom

    Hannah Cohen

  2. Dept. Obstetrics & Gynaecology, University College Hospital, Chenies Mews 86-96, London, WC1E 6HX, United Kingdom

    Patrick O'Brien

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Koita-Kazi, I., Serhal, P. (2012). Thrombotic and Hemostatic Aspects of Assisted Conception. In: Cohen, H., O'Brien, P. (eds) Disorders of Thrombosis and Hemostasis in Pregnancy. Springer, London. https://doi.org/10.1007/978-1-4471-4411-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4411-3_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4410-6

  • Online ISBN: 978-1-4471-4411-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation